84 results
8-K
EX-99.1
APRE
Aprea Therapeutics Inc
10 Apr 24
IND for APR-1051 has been cleared; details on planned Phase 1 first in human trial (ACESOT-1051) presented
4:15pm
acceptance of our current and planned products and services, our research and development efforts, including timing considerations and other matters
8-K
EX-99.2
APRE
Aprea Therapeutics Inc
10 Apr 24
IND for APR-1051 has been cleared; details on planned Phase 1 first in human trial (ACESOT-1051) presented
4:15pm
; the future success of such trials; the successful implementation of our research and development programs and collaborations and the interpretation
8-K
EX-99.1
APRE
Aprea Therapeutics Inc
26 Mar 24
Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
8:15am
inhibitors.
Pipeline – lead candidate for a third synthetic lethality program to be selected in 2024
Aprea’s research and development team has … to an operating loss of $2.7 million in the fourth quarter of 2022.
Research and Development (R&D) expenses were $2.0 million for the quarter ended December
8-K
EX-99.2
APRE
Aprea Therapeutics Inc
26 Mar 24
Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
8:15am
; the future success of such trials; the successful implementation of our research and development programs and collaborations and the interpretation
8-K
EX-99.1
3kb4bl8le 0wkcyb
12 Mar 24
Aprea Therapeutics Announces Private Placement Financing of up to $34.0 Million
4:31pm
8-K
EX-99.2
2xfxfy51cts
12 Mar 24
Aprea Therapeutics Announces Private Placement Financing of up to $34.0 Million
4:31pm
424B3
albsfmsbunfdj 9wq7ae
9 Feb 24
Prospectus supplement
12:00am
8-K
EX-99.1
k6a70s2lf pn7ye2
6 Feb 24
Other Events
5:01pm
424B3
r37dr0tqq1n aj8dofn
5 Feb 24
Prospectus supplement
12:00am
8-K
EX-99.1
qolfepyr73dod ishcvi
4 Jan 24
Aprea Therapeutics Provides Corporate Update and Announces Development Plans for 2024
4:16pm
8-K
EX-99.2
if7idylik
4 Jan 24
Aprea Therapeutics Provides Corporate Update and Announces Development Plans for 2024
4:16pm
8-K
EX-99.1
6lki6dl20b0oib3n 4y
9 Nov 23
Aprea Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update
4:15pm
8-K
EX-99.2
jni5xu21vbqp4mt8 o2b
9 Nov 23
Aprea Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update
4:15pm
8-K
EX-99.1
e6zsquzl l3k
16 Oct 23
Other Events
5:29pm
8-K
EX-99.1
zb241eysum go
13 Oct 23
Other Events
7:31am
8-K
EX-99.1
w5kea8y
11 Sep 23
Other Events
8:30am